• The Most Radical Trumpcare Bill Yet – Tell your senators to VOTE NO on Graham-Cassidy.
    September 20, 2017
    Senate Republicans are making one last push to repeal the Affordable Care Act (ACA) and gut Medicaid and their latest Trumpcare bill known as Graham-Cassidy is the most radical one yet! Pushed by Senators Lindsey Graham (R-SC) and Bill Cassidy (R-LA), the bill repeals the ACA’s consumer protections, allowing insurance companies to once again discriminate against ...
  • FDA Approvals: On a Fast-Track to Disaster
    September 14, 2017
    By Caila Brander, NWHN Policy Fellow Most of us want to be confident when we start a newly prescribed treatment that the medication we take will improve the ailment we seek to treat. We believe that our drugs have been tested and proven effective. We assume that the U.S. Food and Drug Administration (FDA) verifies that ...
  • The Heated Battle for Healthcare
    August 16, 2017
    By Allyson Paiewonsky, NWHN Communications Intern On a hot June day in D.C, I headed to a rally on Capitol Hill to save healthcare with three other summer interns from the National Women’s Health Network. We saw group of protesters waving signs urging the Senate to protect the Affordable Care Act (ACA) and save Medicaid. As ...
  • An NWHN Event to Remember!
    June 20, 2017
    NWHN 2017 Awards Benefit
    Last week, The National Women’s Health Network was proud to host the 10th Annual Barbara Seaman Awards for Activism in Women’s Health. Supporters and members of the National Women’s Health Network celebrated the Network’s recent achievements and recognized the work of two remarkable women, Susan F. Wood and Renee Bracey Sherman. Board Member, Zipatly Mendoza was ...
  • Whose Right to Free Speech? How Pharma is Co-opting the First Amendment for Profit
    June 14, 2017
      By Caila Brander, NWHN Policy Fellow The First Amendment’s protection of free speech is a cornerstone of individual freedom in the United States. However, not all speech is equally protected under the Constitution. Speech that threatens the safety and wellbeing of others can be limited under longstanding legal precedent. Similarly, for most of our nation’s history, ...
  • What You Should Know about Tymlos (Abaloparatide) for Osteoporosis
    May 20, 2017
    By Caila Brander, NWHN Policy Fellow There’s a new kid in town when it comes to osteoporosis drugs. Meet abaloparatide, brand name Tymlos, which was approved by the FDA on April 28, 2017. If you haven’t heard of it yet, you likely will soon, as manufacturer Radius Health is intent on marketing it until it’s also ...
  • Trumpcare and the Return of Rape and Domestic Violence as Pre-existing Conditions
    May 16, 2017
    Recent history demonstrates that even strong state protections may be insufficient in practice to help survivors of rape, sexual assault, or domestic violence. On May 6, the Washington Post published a disconcerting piece denying that the House-passed Trumpcare bill would ultimately lead to discrimination against victims of rape, sexual assault, or domestic violence. Even the headline ...
  • The Trumpcare #zombiebill is back!
    April 27, 2017
      Like the zombie in a bad horror movie that keeps rising, again and again, the Trumpcare bill to repeal the Affordable Care Act (ACA) is once again threatening our health care. With Donald Trump’s 100th day in office just two days away, the media-obsessed White House has been in a panic to notch a win—even ...
  • NWHN Shines a Spotlight on Scott Gottlieb – Why He is Wrong for Women!
    April 4, 2017
    This Wednesday, the Senate Committee on Health, Education, Labor and Pensions (HELP) will consider the nomination of Dr. Scott Gottlieb to head the Food and Drug Administration (FDA) with a floor vote possible at the end of April. Gottlieb has made millions of dollars consulting for and investing in the pharmaceutical industry and continues to be ...
  • Weighing Your Options: Depo-Provera and HIV Risk!
    March 31, 2017
    By Caila Brander, NWHN Policy Fellow Researchers studying the link between contraceptive use and HIV have uncovered a connection between using the Depo-Provera and contracting HIV. In light of these findings, the World Health Organization (WHO) has changed its safety classification for injectable contraception. Depo-Provera is the most widely used injectable contraception around the world, and ...